Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery
- 1 June 2014
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 106, 61-70
- https://doi.org/10.1016/j.antiviral.2014.03.013
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Development of specific dengue virus 2′-O- and N7-methyltransferase assays for antiviral drug screeningAntiviral Research, 2013
- Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 HelicaseAntimicrobial Agents and Chemotherapy, 2013
- Crystal Structure of a Novel Conformational State of the Flavivirus NS3 Protein: Implications for Polyprotein Processing and Viral ReplicationJournal of Virology, 2009
- Structure and functionality in flavivirus NS-proteins: Perspectives for drug designAntiviral Research, 2009
- Ligand efficiency and fragment-based drug discoveryDrug Discovery Today, 2009
- Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Ligand efficiency indices for effective drug discoveryExpert Opinion on Drug Discovery, 2007
- Retrieval of Crystallographically-Derived Molecular Geometry InformationJournal of Chemical Information and Computer Sciences, 2004
- The RNA helicase, nucleotide 5′-triphosphatase, and RNA 5′-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic coreVirology, 2004
- A Structural Basis for the Inhibition of the NS5 Dengue Virus mRNA 2′-O-Methyltransferase Domain by Ribavirin 5′-TriphosphateJournal of Biological Chemistry, 2004